These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6179101)

  • 1. Beta-thromboglobulin and platelet factor 4 plasma levels during haemodialysis: effect of indobufen.
    Pogliani EM; Colombi M; Cristoforetti G; Valenti G; Miradoli R; Buccianti G
    Pharmatherapeutica; 1982; 3(2):127-32. PubMed ID: 6179101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4). Detection of an in vivo thrombocyte activation].
    Hellstern P; Köhler M; Wenzel E
    ZFA (Stuttgart); 1981 May; 57(15):1136-41. PubMed ID: 6167083
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation.
    Vinazzer H; Fuccella LM
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):316-25. PubMed ID: 7400367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of plasma levels of betathromboglobulin and platelet factor 4 during hemodialysis: a possible role for a short acting inhibitor of platelet aggregation.
    Buccianti G; Pogliani E; Miradoli R; Colombi MA; Valenti G; Lorenz M; Polli EE
    Clin Nephrol; 1982 Oct; 18(4):204-8. PubMed ID: 6183040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between low affinity platelet factor 4 (LA-PF4) and beta-thromboglobulin (beta TG).
    Niewiarowski S
    Thromb Haemost; 1980 Aug; 44(1):47. PubMed ID: 6158765
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study between indobufen and acetylsalicylic acid on beta-thromboglobulin, platelet factor 4 and platelet aggregation in patients with transient ischemic attacks.
    Orefice G; Carrieri P; Indaco A; Iorillo L; Fioretti A
    Acta Neurol (Napoli); 1984 Apr; 6(2):97-103. PubMed ID: 6204513
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo.
    Kaplan KL; Owen J
    Blood; 1981 Feb; 57(2):199-202. PubMed ID: 6160890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFP inhibits the expression of the endogenous platelet lectin and secretion of alpha-granules.
    Gartner TK; Walz DA
    Thromb Res; 1983 Jan; 29(1):63-74. PubMed ID: 6188236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery.
    Cella G; Vittadello O; Gallucci V; Girolami A
    Eur J Clin Invest; 1981 Jun; 11(3):165-9. PubMed ID: 6168469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood.
    Pengo V; Boschello M; Prandoni P; Schivazappa L; Girolami A
    Thromb Res; 1985 Sep; 39(5):645-50. PubMed ID: 2417360
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion of low-affinity platelet factor 4 to beta-thromboglobulin by plasmin and trypsin.
    Holt JC; Niewiarowski S
    Biochim Biophys Acta; 1980 Oct; 632(2):284-9. PubMed ID: 6158345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for serotonin binding in vitro by platelet factor 4 and beta-thromboglobulin.
    Heemstra VL
    Thromb Res; 1983 Feb; 29(3):323-32. PubMed ID: 6189240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet secretory activities in acute malaria (Plasmodium falciparum) infection.
    Essien EM; Ebhota MI
    Acta Haematol; 1983; 70(3):183-8. PubMed ID: 6192658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of the platelet alpha-granule release reaction by membrane-active drugs.
    Prowse C; Pepper D; Dawes J
    Thromb Res; 1982 Feb; 25(3):219-27. PubMed ID: 6175045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis].
    Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A
    Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation in man by indobufen (K 3920).
    Vittoria A; Laghi Pasini F; Messa GL; Di Perri T; Corvi G; Fuccella LM
    J Int Med Res; 1981; 9(1):12-7. PubMed ID: 7202826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry, measurement, and clinical significance of platelet specific proteins.
    de Boer AC; Genton E; Turpie AG
    Crit Rev Clin Lab Sci; 1982; 18(2):183-211. PubMed ID: 6185275
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of ticlopidine on coagulation and platelet functions during hemodialysis with cuprophan membranes.
    Grekas D; Syrganis C; Romtsou S; Makris P; Tsakiris DA; Tourkantonis A
    Life Support Syst; 1985; 3 Suppl 1():409-13. PubMed ID: 2959822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of kidney in the catabolic clearance of human platelet antiheparin proteins from rat circulation.
    Bastl CP; Musial J; Kloczewiak M; Guzzo J; Berman I; Niewiarowski S
    Blood; 1981 Feb; 57(2):233-8. PubMed ID: 6160892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.